Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Step by step instructions to Contrast Lab Precious stones and Normal Jewels - 2Katz to Hezbollah chief Qassem: You won't live to see Israel’s full response to Passover attacks
- 3Which Brilliant Home Gadget Can't You Reside Without?
- 4A Concise History Of The Entertainment world
- 5Watch Atlas V rocket launch its heaviest-ever payload early on April 4
- Vote in favor of the pasta that makes good dieting pleasant!
- RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
- What's your biological age? Experts explain the benefits and risks of at-home tests
- Pick Your Number one breakfast food
- Don't miss Jupiter shining close to the waning gibbous moon on Dec. 7
- Artemis II astronauts race to set a new distance record from Earth and behold the moon's far side
- A hospital discharged a woman in labor. This lawmaker wants change.
- Moon memorial: Artemis 2 astronauts name lunar 'bright spot' after mission commander's late wife
- How to watch the 2025 Macy's Thanksgiving Day Parade for free
